Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 119

1.

Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with Lactobacillus reuteri DSM17938.

Savino F, Galliano I, Garro M, Savino A, Daprà V, Montanari P, Bergallo M.

Benef Microbes. 2018 Nov 8:1-10. doi: 10.3920/BM2017.0194. [Epub ahead of print]

PMID:
30406696
2.

Efficacy of an Oral Rehydration Solution Enriched with Lactobacillus reuteri DSM 17938 and Zinc in the Management of Acute Diarrhoea in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial.

Maragkoudaki M, Chouliaras G, Moutafi A, Thomas A, Orfanakou A, Papadopoulou A.

Nutrients. 2018 Sep 1;10(9). pii: E1189. doi: 10.3390/nu10091189.

3.

Mind the gut: probiotics in paediatric neurogastroenterology.

Salvatore S, Pensabene L, Borrelli O, Saps M, Thapar N, Concolino D, Staiano A, Vandenplas Y.

Benef Microbes. 2018 Sep 10:1-16. doi: 10.3920/BM2018.0013. [Epub ahead of print]

PMID:
30198327
4.

Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children.

do Carmo MS, Santos CID, Araújo MC, Girón JA, Fernandes ES, Monteiro-Neto V.

Food Funct. 2018 Oct 17;9(10):5074-5095. doi: 10.1039/c8fo00376a. Review.

PMID:
30183037
5.

Probiotics for management of infantile colic: a systematic review of randomized controlled trials.

Dryl R, Szajewska H.

Arch Med Sci. 2018 Aug;14(5):1137-1143. doi: 10.5114/aoms.2017.66055. Epub 2017 Feb 16. Review.

6.

Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial.

Kołodziej M, Szajewska H.

Clin Microbiol Infect. 2018 Aug 25. pii: S1198-743X(18)30591-3. doi: 10.1016/j.cmi.2018.08.017. [Epub ahead of print]

PMID:
30149135
7.

Lack of Benefit of Lactobacillus Reuteri DSM 17938 as an Addition to the Treatment of Functional Constipation.

Jadrešin O, Sila S, Trivić I, Mišak Z, Hojsak I, Kolaček S.

J Pediatr Gastroenterol Nutr. 2018 Aug 21. doi: 10.1097/MPG.0000000000002134. [Epub ahead of print]

PMID:
30134331
8.

Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against Escherichia coli.

Fijan S, Šulc D, Steyer A.

Int J Environ Res Public Health. 2018 Jul 20;15(7). pii: E1539. doi: 10.3390/ijerph15071539.

9.

Probiotics promoted head growth in extremely low birthweight infants in a double-blind placebo-controlled trial.

Wejryd E, Marchini G, Frimmel V, Jonsson B, Abrahamsson T.

Acta Paediatr. 2018 Jul 12. doi: 10.1111/apa.14497. [Epub ahead of print]

PMID:
29999201
10.

Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.

Wegh CAM, Benninga MA, Tabbers MM.

J Clin Gastroenterol. 2018 Nov/Dec;52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S10-S26. doi: 10.1097/MCG.0000000000001054.

PMID:
29782469
11.

The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.

Wegner A, Banaszkiewicz A, Kierkus J, Landowski P, Korlatowicz-Bilar A, Wiecek S, Kwiecien J, Gawronska A, Dembinski L, Czaja-Bulsa G, Socha P.

Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):494-500. doi: 10.1016/j.clinre.2018.03.008. Epub 2018 Apr 9.

PMID:
29650440
12.

Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2.

Hoang TK, He B, Wang T, Tran DQ, Rhoads JM, Liu Y.

Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G231-G240. doi: 10.1152/ajpgi.00084.2017. Epub 2018 Apr 12.

PMID:
29648878
13.

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis.

Gutiérrez-Castrellón P, Indrio F, Bolio-Galvis A, Jiménez-Gutiérrez C, Jimenez-Escobar I, López-Velázquez G.

Medicine (Baltimore). 2017 Dec;96(51):e9375. doi: 10.1097/MD.0000000000009375. Review.

14.

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis: Erratum.

[No authors listed]

Medicine (Baltimore). 2018 Jan;97(4):e9730. doi: 10.1097/MD.0000000000009730. No abstract available.

15.
16.

Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?

Belei O, Olariu L, Dobrescu A, Marcovici T, Marginean O.

J Neurogastroenterol Motil. 2018 Jan 30;24(1):51-57. doi: 10.5056/jnm17059.

17.

Adenosine A2A Receptor Deletion Blocks the Beneficial Effects of Lactobacillus reuteri in Regulatory T-Deficient Scurfy Mice.

He B, Hoang TK, Tran DQ, Rhoads JM, Liu Y.

Front Immunol. 2017 Dec 6;8:1680. doi: 10.3389/fimmu.2017.01680. eCollection 2017.

18.

Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility.

Indrio F, Riezzo G, Giordano P, Ficarella M, Miolla MP, Martini S, Corvaglia L, Francavilla R.

Nutrients. 2017 Oct 28;9(11). pii: E1181. doi: 10.3390/nu9111181.

19.

Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic.

Nation ML, Dunne EM, Joseph SJ, Mensah FK, Sung V, Satzke C, Tang MLK.

Sci Rep. 2017 Nov 8;7(1):15047. doi: 10.1038/s41598-017-15404-7.

20.

Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.

Riezzo G, Orlando A, D'Attoma B, Linsalata M, Martulli M, Russo F.

Benef Microbes. 2018 Jan 29;9(1):51-60. doi: 10.3920/BM2017.0049. Epub 2017 Oct 12.

PMID:
29022390

Supplemental Content

Loading ...
Support Center